ArticleTranslational lung cancer research2019

Irinotecan, topotecan, paclitaxel or docetaxel for second-line treatment of small cell lung cancer: a single-center retrospective study of efficiency comparation and prognosis analysis.

Yuan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.